Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis

Atopic dermatitis (AD) is a common chronic relapsing pruritic skin disease of dogs for which treatment has varied over time and geographical location. Recent high quality randomized controlled trials and systematic reviews have established which drugs are likely to offer consistent benefit. The International Task Force for Canine AD currently recommends a multi‐faceted approach to treat dogs with AD. Acute flares should be treated with a combination of nonirritating baths and topical glucocorticoids, once an attempt has been made to identify and remove the suspected causes of the flare. Oral glucocorticoids and antimicrobial therapy must be added when needed. In dogs with chronic AD, a combination of interventions should be considered. Again, factors that trigger flares of AD must be identified and, if possible, avoided. Currently recognized flare factors include food, flea and environmental allergens, Staphylococcus bacteria and Malassezia yeast. Skin and coat hygiene and care must be improved by bathing with nonirritating shampoos and dietary supplementation with essential fatty acids. The severity of pruritus and skin lesions can be reduced with a combination of anti‐inflammatory drugs. Currently, medications with good evidence of high efficacy include topical and oral glucocorticoids, and calcineurin inhibitors such as oral ciclosporin and topical tacrolimus. The dose and frequency of administration of these drugs should be tailored to each patient considering each drug’s efficacy, adverse effects and cost. Allergen‐specific immunotherapy should be offered, whenever feasible, in an attempt to prevent recurrence of clinical signs upon further exposure to environmental allergens to which the patient is hypersensitive.     

A retrospective study of canine persistent nasal disease: 80 cases (1998-2003)

Persistent canine nasal disease is a common complaint in small animal practice; however, an etiologic diagnosis can be difficult to establish. The aim of this retrospective study was to determine the percentage of cases for which the etiology was determined in our hospital population. Medical records from 80 dogs met the criteria of inclusion in the study. Nonspecific rhinitis was identified in 23.7% of cases. Other diagnoses were neoplasia (15.0%), fungal infection (nasal aspergillosis) (8.7%), cleft palate (8.7%), periodontal disease (4.0%), parasites (1.3%), foreign body (1.3%), and primary bacterial disease (1.3%). A definitive diagnosis could not be established in 36.3% of cases. Dogs with neoplastic and mycotic diseases often presented with severe radiographic and rhinoscopic lesions. Despite a systematic approach, numerous cases went undiagnosed. The use of advanced imaging should increase our ability to obtain an etiologic diagnosis in canine nasal disease.     

2016年夏季毛皮动物犬瘟热及细小病毒性肠炎抗体检测报告

2016年夏季,采集了国内毛皮动物主产区837份毛皮兽母兽、仔兽、免疫仔兽的血样,分离血清,检测其犬瘟热及细小病毒性肠炎抗体。结果表明:断奶后母兽犬瘟热SN抗体均值为91.6,细小病毒性肠炎HI抗体均值(log2)为10.4,抗体水平高,对两种传染病有足够保护,提供了较高的母源抗体;未免疫仔兽犬瘟热反应抗体下降较快,35 d以上仔兽犬瘟热母源抗体不足以保护仔兽,细小病毒性肠炎HI抗体值较好,对仔兽有很好保护效果;健康动物疫苗免疫后抗体上升较快,免疫后15 d,抗体均值都远高于有效保护值,可以保护动物免于发病。     

Aetiology and prevalence of canine anaemia in Zaria: a review of 2139 cases observed at the Veterinary Teaching Hospital of the Ahmadu Bello University, Zaria, Nigeria (1990-2003)

An investigation was conducted at the Ahmadu Bello University Veterinary Teaching Hospital (ABUVTH) between January, 1990 and September, 2003 to determine the aetiology and prevalence of canine anaemia in Zaria, Nigeria. Out of the 5278 mongrel dogs presented during the period 1990-2003, 2139 (40.5%) were found to be anaemic, with packed cell volume (PCV) values ranging from 7 to 36%. The clinical signs presented by these dogs include: Pale mucous membranes, weakness, depression, anorexia/inapettence and reduced activity. About 50 dogs (about 1%) with helminths and haemoparasitic infestations had high PCV values (37-40%) without clinical presentation of anaemia or disease. Most of the dogs with anaemia (n = 2016 or 94.2%) had parasitic infestations. About 1580 (about 74%) of the anaemic cases, attributed to parasitic infestations occurred between May and October. A few dogs (n = 55, 2.6%) had anaemia due to poor nutrition, while 68 (3.2%) had anaemia with unknown cause. The public health significance of the parasites reported in this study is discussed.     

Clinical, histopathological and epidemiological study of canine straelensiosis in the Iberian Peninsula (2003–2007)

Straelensiosis is a relatively new disease described in dogs and produced by a trombiculid larva known as Straelensia cynotis . Few cases have been reported in the English literature. Straelensiosis has been observed in Southern France and Northern Portugal causing a distinctive nodular dermatitis. The present study describes the clinical, histopathological and epidemiological features of 19 cases diagnosed as straelensiosis in the north of Spain and Portugal (2003–2007). A follow-up of the animals after diagnosis was carried out. Differences with previously described cases were observed, especially concerning epidemiology and histopathology. The grade of response to different treatments and new microscopic features are discussed. The study concludes that S. cynotis can cause a nodular dermatitis in rural and hunting dogs in Spain and Portugal and is associated with particular seasonal and geographical factors.     

表达犬瘟热病毒H基因重组新城疫病毒的构建及其免疫原性研究

为研制安全、有效的新型犬瘟热疫苗,本研究利用新城疫病毒(NDV) LaSota弱毒疫苗株反向遗传操作系统,构建出表达犬瘟热病毒(CDV)弱毒疫苗株Rockborn-20/8血凝素(H)蛋白的重组病毒rLa-CDV-H,并对其生物学特性进行鉴定,评估其作为犬瘟热活载体疫苗的安全性和有效性.通过免疫荧光和western blot试验证明了CDV H蛋白的正确表达;重组病毒株保持了LaSota亲本株的低致病性和高滴度鸡胚生长特性;重组病毒rLa-CDV-H接种12周龄比格犬后,可以诱导显著的CDV中和抗体反应.本研究表明重组病毒rLa-CDV-H具有作为犬瘟热重组病毒活载体疫苗的潜力.     

Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine

Canine visceral leishmaniosis is a life-threatening disease caused by Leishmania infantum. For quite some time, specialists in leishmaniosis have tried to develop more affordable and effective control measures against this disease. In this search, the first vaccine against canine visceral leishmaniosis was recently licensed in Brazil. In the light of recent research, the Leishmune vaccine might be seen as the newest tool for prevention and control of canine visceral leishmaniosis. Moreover, the potential of the Leishmune as a transmission-blocking vaccine has recently been demonstrated, indicating its usefulness in the control of zoonotic visceral leishmaniosis.     

Differential Diagnosis of Some Conditions of the Canine and Feline Thorax : (First Installment)

Routine clinical examination of the chest is described.

The basic principles of viewing X-ray plates are mentioned.

The conditions of the canine and feline thorax dealt with are mostly those which can be confirmed radiologically during life.

The major points of differential diagnosis of each condition are dealt with within groups determined by some cardinal clinical sign. For convenience each condition is dealt with only under one groupheading, although it may have additional signs of some of the other groups.

The groups and conditions are as follows:

Gross Dyspnoea

Hydrothorax

Pyothorax

Pneumothorax

Diaphragmatic hernia

Pneumonia

Cough

Distemper

Tuberculosis

Secondary lung tumour

Filaroides osleri infestation of the trachea

Kennel cough

Feline influenza

Tiring on exercise

Cardiac valvular disease

Congenital cardiac disease

Difficulty in swallowing

Oesophageal foreign body

Feline oesophageal annular carcinoma

Oesophageal diverticulum

Mega-oesophagus (Achalasia)

Oesophageal dilatation associated with

vascular anomalies of the right aortic arch.

     

Adjuvant effects of recombinant giant panda (Ailuropoda melanoleuca) IL-18 on the canine distemper disease vaccine in mice

Canine distemper virus (CDV) is a morbillivirus known to cause morbidity and mortality in a broad range of animals. Giant pandas (Ailuropoda melanoleuca), especially captive ones, are susceptible to natural infection with CDV. Interleukin-18 (IL-18) is a powerful adjuvant molecule that can enhance the development of antigen-specific immunity and vaccine efficacy. In this study, a giant panda IL-18 gene eukaryotic expression plasmid (pcAmIL-18) was constructed. Female BALB/c mice were muscularly inoculated with the plasmids pcAmIL-18, pcDNA3.1 and PBS, respectively. They were subsequently injected with an attenuated CDV vaccine for dogs, and the induced humoral and cellular responses were evaluated. The results showed that pcAmIL-18 remarkably improved the level of specific antibody, IFN-γ and IL-2 in mice sera, the T lymphocyte proliferation index and the percentage of CD4⁺ and CD8⁺ cells. These data indicated that pcAmIL-18 is a potential adjuvant that promotes specific immunity.     

World Association for the Advancement of Veterinary Parasitology (WAAVP) guidelines for evaluating the efficacy of anticoccidial drugs in chickens and turkeys

These guidelines have been written to aid in the design, implementation and interpretation of studies for the assessment of drug efficacy against Eimeria species in chickens and turkeys. The information provided deals with many aspects of how to conduct controlled studies in battery cages (dose determination), floor pens (dose confirmation), and commercial facilities (field effectiveness studies), the selection of birds, housing, feeding, preparation of medicated rations, record keeping, diagnostic techniques, and methods for the preparation, maintenance and use of parasites. These guidelines are also intended to assist investigators in conducting specific studies, provide specific information for registration authorities involved in the decision-making process, assist in the approval and registration of new anticoccidial drugs, and facilitate the world-wide adoption of standard procedures.